PUBLISHER: Grand View Research | PRODUCT CODE: 1632582
PUBLISHER: Grand View Research | PRODUCT CODE: 1632582
The global pancreatic cancer treatment market size is anticipated to reach USD 5.84 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.30% from 2025 to 2030. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.
According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.